Safety has top priority - VACUETTE® CLIX Safety Hypodermic Needle
For many healthcare workers, needlestick injuries carry a high risk of infection with bloodborne pathogens such as hepatitis C and HIV, with recent studies revealing significantly higher levels of affliction amongst people in hospitals than in the wider population(1). Given the trauma experi-enced by those affected as well as the substantial consequential costs, Greiner Bio-One has added another new product to its range of safety solutions in an attempt to eliminate this risk as far as possible. Launched in September 2015, the new VACUETTE® CLIX Safety Hypodermic Needle can be used for taking venous blood samples and for giving injections.
This versatile product comes with a wide range of needle thicknesses and lengths, easily distinguishable thanks to their colour-coded safety shields. One of the most impressive features of the VACUETTE® CLIX Safety Hypodermic Needle is how intuitive it is to use – it is so straightforward that it calls for only minimal training.
The needle has an integrated safety mechanism, which can be activated using a solid surface or the user's thumb. When the user hears a click, they know that the safety shield is positioned securely around the needle and they can proceed without any risk of a needlestick injury.
This product has been designed to be used with the HOLDEX® tube holder, which has an eccentric luer fitting for a flatter puncture angle and thus increased comfort for the patient and user.
1) Himmelreich et al. (2013), Management von Nadelstichverletzungen (The management of needlestick injuries), Dtsch Arztebl; 110(5): 61–7
Greiner Bio-One International GmbH
Greiner Bio-One specialises in the development, production, sale and marketing of high-quality plastic products for use in laboratories. A technology partner to hospitals, laboratories, universities, research institutions, and the diagnostics, pharmaceutical and biotechnology industries, the company is divided into four business divisions: Preanalytics, BioScience, Diagnostics and OEM. Greiner Bio-One International GmbH generated a turnover of EUR 388 million in 2014 and operates in more than 100 countries with over 1800 employees, 23 branches and numerous sales partners. Based in Kremsmünster, Austria, Greiner Bio-One is part of Greiner Holding.